International Patent: AUTOCRINE GLUCOCORTICOID SIGNALING IN HORMONALLY ACTIVE ENDOCRINE AND NON-ENDOCRINE CANCERS INDUCES ANTIGEN EXPRESSION FOR IMMUNOTHERAPY

GENEVA, July 31 -- JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG, IN VERTRETUNG DES FREISTAATES BAYERN filed a patent application (EP2026/052026) for “AUTOCRINE GLUCOCORTICOID SIGNALING IN HORMONALLY ACTIVE ENDOCRINE AND NON-ENDOCRINE CANCERS INDUCES ANTIGEN EXPRESSION FOR IMMUNOTHERAPY”. With publication no. WO/2026/159353, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....